Development of DHQ-based chemical biology probe to profile cellular targets for HBV
- 1 December 2020
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 30 (23) , 127615
Abstract
No abstract availableKeywords
Funding Information
- University Grants Committee
- University of Hong Kong
This publication has 27 references indexed in Scilit:
- Discovery of RG7834: The First-in-Class Selective and Orally Available Small Molecule Hepatitis B Virus Expression Inhibitor with Novel Mechanism of ActionJournal of Medicinal Chemistry, 2018
- Hepatitis B virus: The challenge of an ancient virus with multiple faces and a remarkable replication strategyAntiviral Research, 2018
- A novel orally available small molecule that inhibits hepatitis B virus expressionJournal of Hepatology, 2018
- Discovery of Small Molecule Therapeutics for Treatment of Chronic HBV InfectionACS Infectious Diseases, 2018
- Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term OutcomeThe Journal of Infectious Diseases, 2017
- Design, synthesis, and biological evaluation of new N 4 -Substituted 2′-deoxy-2′-fluoro-4′-azido cytidine derivatives as potent anti-HBV agentsEuropean Journal of Medicinal Chemistry, 2015
- Benzimidazole derivative, BM601, a novel inhibitor of hepatitis B virus and HBsAg secretionAntiviral Research, 2014
- Novel Nucleoside Analogue Fnc is Effective against Both Wild-Type and Lamivudine-Resistant HBV Clinical IsolatesAntiviral Therapy, 2012
- Antiviral Activity of Fnc, 2′-Deoxy-2′-β-Fluoro-4′-Azidocytidine, against Human and Duck HBV ReplicationAntiviral Therapy, 2012
- A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen SecretionAntimicrobial Agents and Chemotherapy, 2007